Baishime Squibb: Myosin inhibitor Maifantuo? Approved in China for the treatment of adult patients with obstructive hypertrophic cardiomyopathy
youki676
发表于 2024-4-30 12:19:59
1156
0
0
On April 30th, Bristol Myers Squibb announced that it was the world's first myocardial myosin inhibitor, Mefantuo& Reg; (Common name: Mavakaitai Capsules) has been given priority review and approval by the National Medical Products Administration of China for the treatment of adult patients with obstructive hypertrophic cardiomyopathy (HCM) in the New York Heart Association (NYHA) heart function classification II-III, in order to improve exercise ability and symptoms.
Logomoney.com is an information publishing platform that only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
-
On May 14th, according to the reference news website citing Bloomberg News, LiDAR manufacturer Hesai Technology Co., Ltd. sued the US Department of Defense for including the company in the list of co ...
- tongcdq
- 3 Dayago
- Up
- Down
- Reply
- Favorite
-
According to a notice issued by Tesla to relevant US government agencies on May 13th local time, Tesla plans to lay off an additional 601 employees in California. Tesla announced last month that it w ...
- yy2433480
- day before yesterday 09:03
- Up
- Down
- Reply
- Favorite
-
The US stock market closed higher, with the Dow Jones Industrial Average up 0.88%, the Nasdaq up 1.40%, and the S&P up 1.17%, all three major indexes reaching historic highs; Large tech stocks genera ...
- hanko
- Yesterday 22:07
- Up
- Down
- Reply
- Favorite
-
Micron predicts that memory prices will continue to rise in 2024, and pricing will increase significantly in the coming quarters.
- sunqingang2001
- 3 Dayago
- Up
- Down
- Reply
- Favorite